These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 27655598)

  • 1. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 2. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
    Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
    Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
    Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
    Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
    Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
    Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
    Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal metabolomic profiles: A comparative study of patients with colorectal cancer
    Nannini G; Meoni G; Tenori L; Ringressi MN; Taddei A; Niccolai E; Baldi S; Russo E; Luchinat C; Amedei A
    World J Gastroenterol; 2021 Oct; 27(38):6430-6441. PubMed ID: 34720532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of 1H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms.
    Chai Y; Wang J; Wang T; Yang Y; Su J; Shi F; Wang J; Zhou X; He B; Ma H; Liu Z
    Radiother Oncol; 2015 Nov; 117(2):294-301. PubMed ID: 26277430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive fecal metabonomic detection of colorectal cancer.
    Phua LC; Chue XP; Koh PK; Cheah PY; Ho HK; Chan EC
    Cancer Biol Ther; 2014 Apr; 15(4):389-97. PubMed ID: 24424155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.
    Sun Y; Zhang X; Hang D; Lau HC; Du J; Liu C; Xie M; Pan Y; Wang L; Liang C; Zhou X; Chen D; Rong J; Zhao Z; Cheung AH; Wu Y; Gou H; Wong CC; Du L; Deng J; Hu Z; Shen H; Miao Y; Yu J
    Cancer Cell; 2024 Aug; 42(8):1386-1400.e8. PubMed ID: 39137727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Fecal Microbiota and Fecal Metabolome in Symptomatic Uncomplicated Diverticular Disease of the Colon.
    Tursi A; Mastromarino P; Capobianco D; Elisei W; Miccheli A; Capuani G; Tomassini A; Campagna G; Picchio M; Giorgetti G; Fabiocchi F; Brandimarte G
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S9-S12. PubMed ID: 27622378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by
    Gu J; Xiao Y; Shu D; Liang X; Hu X; Xie Y; Lin D; Li H
    Dis Markers; 2019; 2019():3491852. PubMed ID: 31089393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of fecal metabolic profiles in patients with irritable bowel syndrome with predominant diarrhea investigated using
    Lee JS; Kim SY; Chun YS; Chun YJ; Shin SY; Choi CH; Choi HK
    Neurogastroenterol Motil; 2020 Jun; 32(6):e13830. PubMed ID: 32125749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ¹H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma.
    Gupta A; Gupta S; Mahdi AA
    Clin Chim Acta; 2015 Feb; 441():47-55. PubMed ID: 25499120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
    Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.